Agreed... The saying goes "Buy when there's blood in the streets." $MYNZ is working towards FDA approval.
Received supportive feedback from the U.S. Food and Drug Administration (FDA) on ColoAlert’s pre-submission package for its U.S. pivotal clinical trial set to commence in Q4 2022.